Abiotic peptides as carriers of information for the encoding of small-molecule library synthesis
        
                            The Pentelute Lab aims to invent new chemistry for the efficient and selective modification of proteins, to ‘hijack’ these biological machines for efficient drug delivery into cells and to create new machines to rapidly and efficiently manufacture peptides and proteins.
                                        Pentelute Lab, Chemistry, MIT, Chemistry Department, Boston, Cambridge, Biology, Peptides, Peptide, Proteins, Science, Rapid, Brad Pentelute, Brad, 
            
            18008
            wp-singular,portfolio_page-template-default,single,single-portfolio_page,postid-18008,wp-theme-bridge,bridge-core-3.0.1,qode-page-transition-enabled,ajax_fade,page_not_loaded,,paspartu_enabled,paspartu_on_top_fixed,paspartu_on_bottom_fixed,qode_grid_1200,qode_popup_menu_push_text_top,qode-theme-ver-28.7,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.8.0,vc_responsive
         
        
    							
		
			
										
					
						
								
                                                                									
																										
Abiotic peptides as carriers of information for the encoding of small-molecule library synthesis
																			
																	
																																			
								                                                             
						 
					 
				 
								 
			 
										
                    					
													
		
				
				
				
					
						
																
																					Abiotic peptides as carriers of information for the encoding of small-molecule library synthesis
																				
																							SIMON L. RÖSSLER, NATHALIE M. GROB, STEPHEN L. BUCHWALD, AND BRADLEY L. PENTELUTE																					
									 
																	
																					Abstract
																				
																							The discovery of therapeutics and biochemical probes hinges on the ability to identify molecules that interact with biological targets of interest. Technologies such as DNA-encoded libraries have transformed the process of drug discovery by enabling the rapid synthesis of vast collections of molecules, each encoded with a unique appendant DNA tag, and their subsequent screening in affinity selection experiments. However, the use of DNA to encode information confers synthetic limitations owing to the incompatibility of oligonucleotides with various chemical reaction conditions that result in the loss of stored information. As a consequence, chemical transformations developed for DNA-encoded library synthesis have to be optimized for oligonucleotide compatibility rather than reaction efficiency and scope. Given the vast potential of encoded library technologies in drug discovery, complementary platforms addressing the limitations of DNA encoding by leveraging carriers of information with higher stability and versatility are desirable.																					
									 
																	
																														
									
Category 
													
													2023, Publications